1. Catalog
  2. The Lead Episode 161: A Discussion of 20 Years: Cl ...
The Lead Episode 161: A Discussion of 20 Years: Clinical Outcome After Pulmonary Vein Isolation in Patients With Symptomatic Drug-Refractory Paroxysmal Atrial Fibrillation
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

Recorded at EHRA 2026, this episode of The Lead features host Christopher Kowalewski, MD, in conversation with Christian Sohns, MD, and Pierre Jaïs, MD, about the journal article, 20 Years: Clinical Outcome After Pulmonary Vein Isolation in Patients With Symptomatic Drug-Refractory Paroxysmal Atrial Fibrillation. Together, they discuss the study's long-term clinical outcomes following pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation and explore the implications of two decades of follow-up.

  • Review the long-term clinical outcomes reported after pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation.
  • Discuss the implications of 20-year follow-up data for the treatment of patients undergoing pulmonary vein isolation.
  • Examine how long-term outcome data may inform clinical decision-making for catheter ablation in paroxysmal atrial fibrillation.

Podcast Contributors

Host: Christopher Kowalewski, MD  

 

Guests:

Christian Sohns, MD 

Pierre Jais, MD 

All relevant financial relationships have been mitigated.

Host and Contributor Disclosure(s):

C. Kowalewski

  • No relevant disclosures

 

C. Sohns

  • No relevant disclosures

 

P. Jais

  • Ownership/Partnership/Prinicipal: inHEART
  • Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Boston Scientific, Medtronic


Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
E. Downward: No relevant financial relationships with ineligible companies to disclose.